2016•LeukemiaOpen access

Duvelisib treatment is associated with altered expression of apoptotic regulators that helps in sensitization of chronic lymphocytic leukemia cells to venetoclax (ABT-199)

Viralkumar Patel, Kumudha Balakrishnan, Mark Douglas, Thomas T. Tibbitts, Ethan Xu, Jeffery L. Kutok, Mark Ayers, Aloke Sarkar, Renato Guerrieri, William G. Wierda, S O'Brien, Nitin Jain, Howard M. Stern, Varsha Gandhi

Open full text 68 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 68 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Venetoclax, Chronic lymphocytic leukemia, Leukemia, Medicine, Cancer research, Ibrutinib, Apoptosis, Lymphoma